European Commission thinking on SPCs under the UPC, Off-patent Drugs Bill failing again in UK, the TPP being published, a WTO TRIPS Council’s decision on a pharma protection exemption request by LDCs, the European Parliament endorsing a plan to increase the number of General Court judges, and a Law Society report on Brexit and IP were in the recent IP headlines in Europe
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
The Unitary Patent has passed 100,000 registrations, but new data raises the question of whether 30% uptake is a ceiling or a staging post for further growth, say Michael Nielsen and Darren Smyth of EIP and Andrew Samm at Patently
The new generation of in-house IP leaders want commercial judgment, accessibility and flexibility, with AI raising expectations around both fees and delivery
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
SKW Schwarz partner Daniel Kendziur explains how new green claims rules are changing his workload and bringing him into direct contact with marketing, PR and government affairs teams
The government is targeting earlier resolution of SEP disputes while ruling out a standalone IPEC rate determination track and restrictions on injunctions